医師紹介

賀古 眞医師

消化器病センター顧問

賀古 眞MAKOTO KAKO

専門分野肝臓

1970年 東京大学医学部卒業
1996年 帝京大学医学部第4内科主任教授
2000年 社会保険都南総合病院院長
2003年 府中恵仁会病院院長
2010年 湘南鎌倉総合病院 肝胆膵疾患治療センター長
2013年 湘南鎌倉総合病院 消化器病センター長
2018年 湘南鎌倉総合病院 消化器病センター顧問

所属学会

  • 日本肝臓学会指導医
  • 日本消化器病学会指導医
  • 日本肝臓学会専門医
  • 日本消化器病学会専門医
  • 日本内科学会認定内科医

 

業績

【学会発表】

  1. Kazuhiro Abe, Hiroshi Miyakwa, Kiyomitsu Miyachi, Makoto Kako and Hisashi Furue: Anti-Liver / Kidney MicrosmeーⅠ-Positive Chronic Hepatitis C with Type Ⅰ Cryoglobulinemia Responding to Interferon.
    Internal Medicine 34(11):1114-1119,1995
  2. Hiroshi Miyakawa, Kazuhiro Abe, Makoto Kako : So-Called  “Autoimmune Hepatitis Type Ⅱb” is not categorized in Autoimmune Hepatitis. A J G 1365,1995
  3. Hiroshi Miyakawa, Kazuhiro Abe, Makoto Kako : Heterogeneity of
    Autoantigens to anti-liver/kidney microsome 1 (LKM1): analysis by western blotting.
    International Hepatology Communication 3:1-5, 1995
  4. T. Aikawa, K. Kanai, M. Kako, T. Kawasaki, K. Hino, S. Iwabuchi, H.Tsubouchi, Y. Takehira, F. Tsuda, H. Okamoto, Y. Miyakawa and M. Mayumi: Interferon―α2a for chronic hepatitis B with e antigen or antibody: comparable antiviral effects on wild-type virus and precore mutant. Journal of Viral Hepatitis 2:243-250,1995
  5. Koichi Kanai, Makoto Kako, Tatsuya Aikawa, Takashi Kumada, Tsunehisa Kawasaki, Terumasa Hatahara, Yuji Oka, Masashi Mizokami, Takahiro Sakai, Koichiro Iwata, Hiroaki Okamoto and Makoto Mayumi:
    Clearance of serum hepatitis C virus RNA after interferon therapy in relation to viral genotype. Liver 15:185-188,1995
  6. K. Kanai, M. Kako, T. Aikawa, T. Kumada, T. Kawasaki, T. Hatahara, Y. Oka, M. Mizokami, T. Sakai, K. Iwata, H. Okamoto, M. Mayumi and S. Mishiro: HCV RNA monitoring for tailored regimens of interferon therapy in hepatitis C. Biomed & Pharmacother 49:65-67,1995
  7. Koichi Kanai, Makoto Kako, Tatsuya Aikawa, Kunihiko Hino, Hirohito Tsubouchi, Yasunori Takehira, Shogo Iwabuchi, Tsunehisa Kawasaki, Fumio Tsuda, Hiroaki Okamoto, Yuzo Miyakawa and Makoto Mayumi: Core Promotor Mutations of Hepatitis B Virus for the Response to Interferon in e Antigen-positive Chronic Hepatitis B. AJG 91:2150-2156,1966
  8. Makoto Kako, Koichi Kanai, Tatsuya Aikawa, Shogo Iwabuchi, Yasunori Takehira, Tsunehisa Kawasaki, Hirohito Tsubouchi, Kunihiko Hino, Fumio Tsuda, Hiroaki Okamoto, Yuzo Miyakawa, Makoto Mayumi: Response to Interferon-α2a in Patients with e Antigen-Negative Chronic Hepatitis B. J Clin Gastroenterol 25(2):440-445,1997
  9. 賀古 眞:B型慢性肝炎のインターフェロン治療の進めかたと有効性 Medical Practice 14(11):1821-1824,1997
  10. 金井 弘一、賀古 眞、相川 達也、日野 邦彦, 坪内 博仁、竹平 安則、 岩淵 省吾、河崎 恒久、津田 文男、岡本 宏明、真弓 忠:B型慢性肝炎に対するIFN24週間投与 肝臓39(2)62-67、1998
  11. K. Kanai, M. Kako, T. Kumada, H. Tsubouchi, T. Aikawa, M. Kojima, H. Harada, T. Kawasaki, M. Nakajima, H. Okamoto and S. Mishiro: High-dose(9MU) long-term(60 weeks) alfa-interferon therapy for chronic hepatitis patients infected with HCV genotype 1b. Arch Virol 143:1545-1554,1998
  12. K. Miyachi, H. Matsushima, R. W. Hankins, M. Hirakata, T. Mimori, H. Hosaka, Y. Amagasaki, H. Miyakawa, M. Kako, M. Shibata, Y. Onozuka and U.Ueno : A Novel Antibody Directed Against a Three―Dimentional Configuration of a 95- kDa Protein in Patients with Autoimmune Hepatic Diseases. Scand. J. Immunol 47:63-68,1998
  13. Hiroshi Miyakawa, Naomi Kawaguchi, Kentaro Kikuchi, Hirotoshi Fujikawa, Eriko Kitazawa, Masanao Matsushita, Kazuhiro Abe, Makoto Kako: Combination assays for IgG class and IgM class anti-pyruvate dehydrogenase complex (PDC) -E2 by ELISA using recombinant autoantigen to diagnose primary biliary cirrhosis. Hepatology Research 12:140-150,1998
  14. Hiroshi Miyakawa, Hiroshi matsushima, Yoichi Narita, Raleigh W. Hankins, Eriko Kitazawa, Hirotoshi Fujikawa, Kentaro Kikuchi, Masanao Matsushita, Kazuhiro Abe, Naomi Kawaguchi, Toshio Morizane, and Makoto Kako: Differences in antigenic sites, recognized by anti-liver-kidney microsome-1 (LKM-1) autoantibody, between HCV-positive and HCV-negative sera in Japanese patients. J Gastroenterol 33:529-535,1998
  15. Hiroshi Miyakawa, Eriko Kitazawa, Kazuhiro Abe, Masanao Matsushita, Naomi Kawaguchi, Hirotoshi Fujikawa, Kentaro Kikuchi, Makoto Kako: Anti-liver-kidney microsome-1 autoantibody in HCV-positive sera reacts predominantly to conformational epitope, not to linear epitope. Hepatology Research 10:112-120,1998
  16. Hiroshi Miyakawa, Naomi Kawaguchi, Kazuhiro Abe, Eriko Kitazawa, Kentaro Kikuchi, Hirotoshi Fujikawa, Masanao Matsushita, Makoto Kako: Serial changes of serum anti-M2 proteins in patients with primary biliary cirrhosis: a follow-up study by immunoblotting.
    Hepatology Research 13:143-152,1999
  17. Hiroshi Miyakawa, Kazuhiro Abe, Eriko Kitazawa, Kentaro Kikuchi, Hirotoshi Fujikawa, Masanao Matsushita, Naomi Kawaguchi, and Makoto Kako: Detection of Anti-branched Chain2―Oxo Acid Dehydrogenase Complex ( BCOADC )-E2 Antibody in Primary Biliary Cirrhosis by ELISA using Recombinant Fusion Protein. Autoimmunity 30:11-20,1999

 

メディア掲載